EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers

Tetiana Korzun iD, Abraham S Moses iD, Parham Diba iD, Ariana L Sattler iD, Brennan Olson iD, Olena R Taratula iD, Tanja Pejovic, Daniel L Marks iD, Oleh Taratula iD

Small · 2023

DOI: 10.1002/smll.202301776 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, 2023. Verfasst von Tetiana Korzun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, 2730 S Moody Avenue, Portland, OR, 97201, USA. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, Nanomedicine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 286 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gynecological malignancies are a significant cause of morbidity and mortality across the globe. Due to delayed presentation, gynecological cancer patients are often referred late in the disease's course, resulting in poor outcomes. A considerable number of patients ultimately succumb to chemotherapy‐resistant disease, which reoccurs at advanced stages despite treatment interventions. Although efforts have been devoted to developing therapies that demonstrate reduced resistance to chemotherapy and enhanced toxicity profiles, current clinical outcomes remain unsatisfactory due to treatment resistance and unfavorable off‐target effects. Consequently, innovative biological and nanotherapeutic approaches are imperative to strengthen and optimize the therapeutic arsenal for gynecological cancers. Advancements in nanotechnology‐based therapies for gynecological malignancies offer significant advantages, including reduced toxicity, expanded drug circulation, and optimized therapeutic dosing, ultimately leading to enhanced treatment effectiveness. Recent advances in nucleic acid therapeutics using microRNA, small interfering RNA, and messenger RNA provide novel approaches for cancer therapeutics. Effective single‐agent and combinatorial nucleic acid therapeutics for gynecological malignancies have the potential to transform cancer treatment by giving safer, more tailored approaches than conventional therapies. This review highlights current preclinical studies that effectively exploit these approaches for the treatment of gynecological malignant tumors and malignant ascites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genital Neoplasms, FemaleNanomedicineHumansFemaleNucleic AcidsAnimals

Stichwörter der Autor:innen

gynecological cancernanomedicinenucleic acid therapy

Substanzen

Nucleic Acids

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, 2730 S Moody Avenue, Portland, OR, 97201, USA.
  • Department of Biomedical Engineering, Oregon Health & Science University, 3303 SW Bond Avenue Portland, Portland, OR, 97239, USA.
  • Medical Scientist Training Program, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.
  • Papé Family Pediatric Research Institute, Oregon Health & Science University, SW Sam Jackson Park Rd, Mail Code L481, Portland, OR, 97239, USA.
  • Knight Cancer Institute, Oregon Health & Science University, 2720 S Moody Avenue, Portland, Oregon, 97201, USA.
  • Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University, 2730 S Moody Avenue, Portland, OR, 97201, USA.

ORCID-Profile: Tetiana Korzun, Abraham S Moses, Parham Diba, Ariana L Sattler, Brennan Olson, Olena R Taratula, Daniel L Marks, Oleh Taratula

Förderung

  • NICHD NIH HHS
  • NIH HHS
  • NCATS NIH HHS
  • NCI NIH HHS
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • OHSU Knight Cancer Institute
  • Friends of Doernbecher
  • National Cancer Institute

Zitieren

APA

Korzun, T., Moses, A. S., Diba, P., Sattler, A. L., Olson, B., Taratula, O. R., Pejovic, T., Marks, D. L., & Taratula, O. (2023). Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers. Small. https://doi.org/10.1002/smll.202301776

Vancouver

Korzun T, Moses AS, Diba P, Sattler AL, Olson B, Taratula OR, et al. Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers. Small. 2023. doi:10.1002/smll.202301776

BibTeX
@article{Korzun2023,
  author = {Korzun, Tetiana and Moses, Abraham S and Diba, Parham and Sattler, Ariana L and Olson, Brennan and Taratula, Olena R and Pejovic, Tanja and Marks, Daniel L and Taratula, Oleh},
  title = {Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers},
  journal = {Small},
  year = {2023},
  doi = {10.1002/smll.202301776}
}
Kostenlos starten →